Dr. David Epstein Joins Aerie Pharmaceuticals Advisory Board

Aerie Pharmaceuticals has named David Epstein, MD, a board-certified ophthalmologist, as chairman of the company’s scientific advisory board.

Advertisement

Dr. Epstein is a co-founder of Aerie and chairman of Duke University’s ophthalmology department.

Aerie has also named Vicente Anido, Jr., PhD, an ophthalmology industry expert, as its chairman of the board.

More Articles on Ophthalmology:
InSite Vision Receives $15M in Royalties for Pink-Eye Treatment
IRIDEX, Peregrine Surgical Partner
Dr. Kenneth Pearlberg Joins Medifirst Solutions Advisory Board

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.